A detailed history of Cwm, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Cwm, LLC holds 417 shares of IMVT stock, worth $11,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares
417
Previous 315 32.38%
Holding current value
$11,471
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$27.51 - $27.51 $2,806 - $2,806
102 Added 32.38%
417 $12,000
Q2 2024

Jul 09, 2024

BUY
$25.1 - $31.61 $6,576 - $8,281
262 Added 494.34%
315 $8,000
Q1 2024

Apr 05, 2024

BUY
$30.27 - $43.79 $1,543 - $2,233
51 Added 2550.0%
53 $2,000
Q4 2023

Feb 01, 2024

SELL
$31.31 - $44.19 $31 - $44
-1 Reduced 33.33%
2 $0
Q2 2023

Aug 03, 2023

BUY
$14.2 - $23.75 $42 - $71
3 New
3 $0

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.